ES2059129T3 - Procedimiento para la produccion de plasma sanguineo no infeccioso. - Google Patents

Procedimiento para la produccion de plasma sanguineo no infeccioso.

Info

Publication number
ES2059129T3
ES2059129T3 ES91906410T ES91906410T ES2059129T3 ES 2059129 T3 ES2059129 T3 ES 2059129T3 ES 91906410 T ES91906410 T ES 91906410T ES 91906410 T ES91906410 T ES 91906410T ES 2059129 T3 ES2059129 T3 ES 2059129T3
Authority
ES
Spain
Prior art keywords
production
blood plasma
procedure
infectious blood
ionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91906410T
Other languages
English (en)
Spanish (es)
Inventor
Dieter Wolter
Horst Schwinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Blood Center
Original Assignee
New York Blood Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6402597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2059129(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New York Blood Center filed Critical New York Blood Center
Application granted granted Critical
Publication of ES2059129T3 publication Critical patent/ES2059129T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES91906410T 1990-03-20 1991-03-16 Procedimiento para la produccion de plasma sanguineo no infeccioso. Expired - Lifetime ES2059129T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4008852A DE4008852A1 (de) 1990-03-20 1990-03-20 Verfahren zur herstellung von nicht-infektioesem blutplasma

Publications (1)

Publication Number Publication Date
ES2059129T3 true ES2059129T3 (es) 1994-11-01

Family

ID=6402597

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91906410T Expired - Lifetime ES2059129T3 (es) 1990-03-20 1991-03-16 Procedimiento para la produccion de plasma sanguineo no infeccioso.

Country Status (8)

Country Link
EP (1) EP0472708B1 (enExample)
JP (1) JP2708632B2 (enExample)
AT (1) ATE110272T1 (enExample)
DE (3) DE4008852A1 (enExample)
DK (1) DK0472708T3 (enExample)
ES (1) ES2059129T3 (enExample)
FI (1) FI101128B (enExample)
WO (1) WO1991014439A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639376A (en) * 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
CA2180328A1 (en) * 1994-01-10 1995-07-13 Franco Castino Device and process for removing leukocytes and viral inactivating agents from blood
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
DE19729778A1 (de) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten
EP0896824A1 (en) † 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
CN1302009C (zh) * 2005-09-05 2007-02-28 武汉海特生物制药股份有限公司 用有机溶剂病毒灭活法制备鼠神经生长因子的工艺
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE3173208D1 (en) * 1980-10-06 1986-01-23 Edward Shanbrom Method of reducing undesirable activities of biological and pharmaceutical products
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
EP0367840B1 (de) * 1988-11-05 1993-02-03 Octapharma AG Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie

Also Published As

Publication number Publication date
DE4021542A1 (de) 1992-01-09
EP0472708B1 (de) 1994-08-24
ATE110272T1 (de) 1994-09-15
DK0472708T3 (da) 1994-09-19
FI915301A0 (fi) 1991-11-11
JPH04506668A (ja) 1992-11-19
EP0472708A1 (de) 1992-03-04
WO1991014439A1 (de) 1991-10-03
FI101128B (fi) 1998-04-30
DE4021542C2 (de) 1995-08-17
JP2708632B2 (ja) 1998-02-04
DE4008852A1 (de) 1991-09-26
DE4008852C2 (enExample) 1992-06-17
DE59102623D1 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
MX170032B (es) Procedimiento para la extraccion de materiales solidos empleando un solvente y aparato para llevar a cabo el mismo
ES2056890T3 (es) Procedimiento para la produccion de un preparado que abarca por lo menos una sustancia activa y un vehiculo.
ES2086229T3 (es) Procedimiento para la obtencion de preparados medicinales de accion retardada.
AR029786A1 (es) Estructura absorbente que comprende un elemento absorbente integral que tiene una superficie superior y una superficie inferior que definen entre las mismas un espesor de elemento absorbente, articulo absorbente que comprende dicha estructura y aparato para producirla
EA199900344A1 (ru) Воздухопроницаемые эластичные полимерные пленочные слоистые материалы
NL193831B (nl) Werkwijze voor de bereiding van zwaardere koolwaterstoffen uit lichte, gasvormige koolwaterstoffen.
ES2027297T3 (es) Metodo y aparato para envasado al vacio.
FR2703263B1 (fr) Procédé de préparation de sphérules de principes actifs.
ATE66856T1 (de) Formkoerper zum tiefziehen von folien und vergiessen von werkstoffen.
AR246207A1 (es) Procedimiento para la formacion del borde de contenedores de material sintetico termoplastico y maquina para su realizacion.
DE69607963D1 (de) Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit
ATE110272T1 (de) Verfahren zur herstellung von nicht-infektiösem blutplasma.
MX9102628A (es) Metodo y maquina para eliminar contaminantes de la superficie de un articulo.
ES2098419T3 (es) Procedimiento para el tratamiento de residuos procedentes de la mecanizacion de materiales ferromagneticos.
AR247658A1 (es) Proceso y aparato para procesar carne
ES2193210T3 (es) Separacion de virus de soluciones de proteinas por ultrafiltracion.
AR036538A1 (es) Metodo y aparato para separar articulos moldeados
DE68918518D1 (de) Verfahren und Vorrichtung zum Erzeugen von differentiellen Spannungen bei der Herstellung von endlosen, flexiblen, metallischen Giessbändern zum Verbessern der Bandleistung in Stranggiessmaschinen.
ES2048142T3 (es) Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
ES2112244T3 (es) Compuestos de disulfuro del complejo ll-33288.
ES2102428T3 (es) Procedimiento para la preparacion de mezclas de plasticos.
ATE91459T1 (de) Verfahren zum herstellen von augenprothesen, sklerotischen linsen und kontaktlinsen, sowie nach dem verfahren hergestellte gegenstaende.
ES2184889T3 (es) Metodo y aparato para la produccion de correas sincronicas que constan de al menos dos pistas dentadas helicoidales.
ES2071081T3 (es) Liposomas fosfolipidicos que contienen principios activos y un procedimiento para su obtencion.
ES2099477T3 (es) Procedimiento para separar enantiomeros a partir de una mezcla racemica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 472708

Country of ref document: ES